Publication
Paradoxical Pulmonary Event Under Tocilizumab Treatment for Systemic Sclerosis-Associated Usual Interstitial Pneumonia
| dc.contributor.author | Oliveira, AL | |
| dc.contributor.author | Ruano, C | |
| dc.contributor.author | Riso, N | |
| dc.contributor.author | Cepeda Ribeiro, J | |
| dc.contributor.author | Moraes-Fontes, MF | |
| dc.date.accessioned | 2023-05-22T15:32:21Z | |
| dc.date.available | 2023-05-22T15:32:21Z | |
| dc.date.issued | 2020 | |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Ann Rheum Dis . 2020 Feb;79(2):e22. | pt_PT |
| dc.identifier.doi | 10.1136/annrheumdis-2018-214747 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/4525 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | BMJ | pt_PT |
| dc.subject | HCC DAUTOIM | pt_PT |
| dc.subject | HSM IMA | pt_PT |
| dc.subject | Antibodies, Monoclonal, Humanized | pt_PT |
| dc.subject | Humans | pt_PT |
| dc.subject | Lung | pt_PT |
| dc.subject | Idiopathic Pulmonary Fibrosis* | pt_PT |
| dc.subject | Scleroderma, Systemic* | pt_PT |
| dc.title | Paradoxical Pulmonary Event Under Tocilizumab Treatment for Systemic Sclerosis-Associated Usual Interstitial Pneumonia | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 2 | pt_PT |
| oaire.citation.startPage | e22 | pt_PT |
| oaire.citation.title | Annals of the Rheumatic Diseases | pt_PT |
| oaire.citation.volume | 79 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |